Table 3. Analysis of peritumoral edema and strong contrast enhancement using logistic regression models.
| Variables | n (% with edema/strong contrast enhancement) | Odds ratio | 95%-confidence interval | p-value | |
|---|---|---|---|---|---|
| Peritumoral edema | |||||
| Tumor type | mGBM-H3wt | 15/19 (79) | REF. | ||
| DMG | 6/24 (25) | 0.13 | [0.02–0.62] | 0.010 | |
| MVP | No | 1/9 (11) | REF. | ||
| Yes | 20/34 (59) | 4.00 | [0.38–41.51] | 0.246 | |
| Strong Contrast enhancement | |||||
| Tumor type | mGBM-H3wt | 10/19 (53) | REF. | ||
| DMG | 3/24 (12.5) | 0.10 | [0.02–0.47] | 0.003 | |
DMG: Diffuse midline glioma, H3 K27M-mutant; mGBM-H3wt: Glioblastoma of the midline structures without H3F3A/HIST1H3B mutations; REF.: Reference group; MVP: Microvascular proliferations.